Mitsides, N.; Mitra, V.; Saha, A.; Harris, S.; Kalra, P.A.; Mitra, S.
Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease. J. Pers. Med. 2023, 13, 1481.
https://doi.org/10.3390/jpm13101481
AMA Style
Mitsides N, Mitra V, Saha A, Harris S, Kalra PA, Mitra S.
Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease. Journal of Personalized Medicine. 2023; 13(10):1481.
https://doi.org/10.3390/jpm13101481
Chicago/Turabian Style
Mitsides, Nicos, Vikram Mitra, Ananya Saha, Shelly Harris, Philip A. Kalra, and Sandip Mitra.
2023. "Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease" Journal of Personalized Medicine 13, no. 10: 1481.
https://doi.org/10.3390/jpm13101481
APA Style
Mitsides, N., Mitra, V., Saha, A., Harris, S., Kalra, P. A., & Mitra, S.
(2023). Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease. Journal of Personalized Medicine, 13(10), 1481.
https://doi.org/10.3390/jpm13101481